-

Henry Schein to Showcase Diverse Portfolio of Products at the AAOMS Annual Conference, Sept. 12 – 17, 2022

Company Committed to Providing Oral Surgeons with a Comprehensive Array of Dental and Medical Solutions

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced its lineup of products and solutions at the American Association of Oral and Maxillofacial Surgeons (AAOMS) Annual Conference in New Orleans, La. from September 12 through September 17.

Visitors at Henry Schein’s booth (#801) can explore the Company’s vast surgical product offerings that help meet the unique needs of oral surgeons, and attendees can speak with Henry Schein Dental representatives as well as Henry Schein Surgical Solutions Specialists, who exclusively serve the ambulatory surgery center and oral and maxillofacial surgery (OMS) markets.

Throughout the meeting, Henry Schein will present the latest technology, including 3D printers, intraoral scanners, air purification systems, and emergency medication management, patient monitoring, and anesthesia solutions. Members of the Henry Schein Dental and Henry Schein Surgical Solutions teams, along with representatives from HealthFirst, a subsidiary of Henry Schein, will be available to answer questions and suggest customized solutions. Product demonstrations will include the Avante Anesthesia Portable Unit, HealthFirst AED, HealthFirst ActivePure™ Surface and Air Guardian, HealthFirst Crash Cart, Mindray Patient Monitor, Mindray Anesthesia System, Planmeca Emerald S and Planmeca’s Romexis software, Primescan, Medit i700, and SprintRay Procure Wash/Dry Ecosystem.

Henry Schein representatives will also be available to discuss Henry Schein® Brand Products, which includes sutures, gauzes, surgical gloves, needles, and intravenous therapy sets. Attendees can also learn about Henry Schein’s custom and standard oral surgery procedure kits, which contain the core components needed for surgery and help drive efficiencies in operating room set-up time.

“At Henry Schein, we have the products that oral and maxillofacial surgeons need to provide high-quality patient care,” said Erica Smith, Surgical Solutions Manager at Henry Schein Medical. “Our Surgical Solutions team has the knowledge and expertise to support both the dental and medical sides of the profession.

“Because of our long track record supporting the needs of both dentists and physicians, oral and maxillofacial surgeons can rely on us as a one-stop-shop for all their facility essentials. We are dedicated to being trusted advisors and consultants to our customers, enabling them to enhance their efficiency and profitability. We look forward to connecting with our customers and the OMS community at this year’s AAOMS conference,” added Ms. Smith.

For more information about Henry Schein’s offerings for oral surgeons, click here or email Henry Schein Surgical Solutions Specialists at SurgicalSolutions@henryschein.com.

About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 22,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.4 billion in 2021, and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, and Twitter.com/HenrySchein.

Contacts

Ann Marie Gothard
Vice President, Global Corporate Media Relations
annmarie.gothard@henryschein.com
(631) 390-8169

Henry Schein, Inc.

NASDAQ:HSIC

Release Versions

Contacts

Ann Marie Gothard
Vice President, Global Corporate Media Relations
annmarie.gothard@henryschein.com
(631) 390-8169

More News From Henry Schein, Inc.

Henry Schein Expands Partnership with vVARDIS

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) today announced the expansion of its agreement with vVARDIS, which grants the Company exclusive U.S. distribution rights for the drill-free Curodont™ Repair Fluoride Plus (“Curodont”) product across all dental market segments, effective January 1, 2026. The strategic expansion broadens Henry Schein’s previous exclusivity with the Swiss company, which was announced in 2024 for Dental Service Organizations (DSOs). Starting next ye...

Henry Schein to Participate in Upcoming Investor Conference in December

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., (Nasdaq: HSIC) the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in December: Piper Sandler’s Healthcare Conference at the Lotte New York Palace Hotel, New York, on December 2, 2025, at 9:00 a.m. Eastern time. Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcas...

Henry Schein Reports Record Third Quarter 2025 Financial Results and Raises Full Year Non-GAAP EPS Guidance

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended September 27, 2025. “We are pleased with our financial results for the third quarter, with sales growth accelerating in each of our reportable segments including solid market share gains in our distribution businesses as we are once again focused on driving growth n...
Back to Newsroom